A recent OECD report offers new evidence on the impact of R&D tax incentives and direct funding of business R&D. The new analysis reveals that both types of support lead to different outcomes but similar increases in R&D performance.
Organization: National Research Council
The St. John’s, Newfoundland-based tech startup Avalon Holographics launched its first-generation prototype display; the federal government will launch the first round of its $300-million Housing Supply Challenge, focused on the provision of reliable housing data; Alberta Premier Jason Kenney put Doug Schweitzer at the head of his new ministry of Jobs, Economy and Innovation; and more.
Statistics Canada reported record gains in Canadian manufacturing sales; the underlying technology for a COVID-19 vaccine currently being blocked from entering Canada was licensed by the NRC; the Competition Bureau of Canada is investigating Amazon.ca to determine if the site is engaging in anti-competitive practices; and more.
Planning needs to begin now for the next disease outbreak, beginning with stronger linkages between human and animal research facilities.
Putting Ottawa’s grand rescue plan for Canadian SMEs in context
The NRC is deploying $45 million in new funding to help combat the ongoing pandemic, with two new challenge programs and upgrades to its Human Health Therapeutics Lab in Montreal.
Canada’s Tri-Council of major government funding agencies and Indigenous partners across the country have co-developed a new Indigenous research strategic plan. The plan, which proposes a new interdisciplinary research and research screening model, represents a significant new approach by the federal government and a contribution to reconciliation. With implementation starting this spring, the strategy aims to ensure Indigenous peoples lead and control any research involving them.
A common refrain in Canadian innovation circles holds that Canada “punches above its weight” in research strength. While this is certainly true, we still lag other OECD countries on productivity and innovation. What’s the point of punching above our weight in research if we’re still getting clobbered on commercialization?
With the goal becoming a mainstream healthcare company, Smiths Falls, ON-based Canopy Growth Corp. has spun off a new division – Spectrum Therapeutics – to oversee the company’s commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations, and recently acquired Germany-based C3Cannabinoid Compound Company, which develops cannabinoid-based medical therapies. – Canopy Growth…
Universities and industry have made progress adapting to new realities for entrepreneurship and innovation, but government programs are still catching up.